Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00299494
Status:
COMPLETED
Last Update Posted:
2018-03-08
First Post:
2006-03-02
Brief Title:
Study Evaluating Inotuzumab Ozogamicin CMC-544 Administered In Combination With Rituximab In Subjects With Non-Hodgkins Lymphoma NHL
Sponsor:
Pfizer
Organization:
Pfizer
Organization Data
Organization:
Pfizer
Class:
INDUSTRY
Study ID:
3129K3-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| UCB Pharma | INDUSTRY |